Literature DB >> 33911216

HSV-1 G207 is active in paediatric glioma.

Diana Romero1.   

Abstract

Entities:  

Year:  2021        PMID: 33911216     DOI: 10.1038/s41571-021-00515-y

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.

Authors:  Gregory K Friedman; James M Johnston; Asim K Bag; Joshua D Bernstock; Rong Li; Inmaculada Aban; Kara Kachurak; Li Nan; Kyung-Don Kang; Stacie Totsch; Charles Schlappi; Allison M Martin; Devang Pastakia; Rene McNall-Knapp; Sameer Farouk Sait; Yasmin Khakoo; Matthias A Karajannis; Karina Woodling; Joshua D Palmer; Diana S Osorio; Jeffrey Leonard; Mohamed S Abdelbaki; Avi Madan-Swain; T Prescott Atkinson; Richard J Whitley; John B Fiveash; James M Markert; G Yancey Gillespie
Journal:  N Engl J Med       Date:  2021-04-10       Impact factor: 91.245

  1 in total
  1 in total

Review 1.  Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy.

Authors:  Zhongbing Qi; Xiangyu Long; Jiyan Liu; Ping Cheng
Journal:  Front Cell Neurosci       Date:  2022-09-09       Impact factor: 6.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.